Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/7/2026

Management of Wounds with Eschar

Primary Recommendation

  • The American College of Cardiology is not mentioned, however, for a large, stable, dry eschar on the leg, leave the adherent eschar in place until it softens enough to be more easily removed, provided there is no underlying infection 1

Initial Assessment Algorithm

Evaluate for Infection

  • Examine for at least two signs of inflammation: redness, warmth, induration, pain/tenderness, or purulent secretions, as recommended by the Diabetes/Metabolism Research and Reviews 2
  • Note that these signs may be blunted by neuropathy or ischemia, and systemic findings (fever, elevated white blood count) are often absent, according to the Diabetes/Metabolism Research and Reviews 2

Assess Vascular Status

  • Check dorsalis pedis and posterior tibial pulses; if palpable, arterial supply is generally adequate, as stated by the Praxis Medical Insights 3
  • Measure ankle pressure and ankle-brachial index (ABI), as recommended by the Diabetes/Metabolism Research and Reviews 2
  • If ankle pressure <50 mmHg or ABI <0.5, obtain urgent vascular imaging and consider revascularization, according to the Diabetes/Metabolism Research and Reviews 2

Management Based on Clinical Scenario

Stable Eschar WITHOUT Infection

  • Leave the eschar in place and monitor regularly, as recommended by the Praxis Medical Insights 1

Eschar WITH Signs of Infection

  • Urgent surgical consultation is required, according to the Praxis Medical Insights 1
  • Obtain specimens for aerobic and anaerobic culture before initiating antibiotics, as recommended by the Clinical Infectious Diseases 4

Debridement Techniques When Indicated

Sharp Debridement (Preferred Method)

  • Sharp debridement with scalpel, scissors, or tissue nippers is the preferred technique when debridement is necessary, as stated by the Diabetes/Metabolism Research and Reviews and Clinical Infectious Diseases 5, 6, 1

Wound Dressing Selection

  • Select dressings based on wound characteristics, as recommended by the Clinical Infectious Diseases and Praxis Medical Insights 6, 3

Special Considerations for Diabetic Patients

Osteomyelitis Evaluation

  • Consider osteomyelitis as a potential complication of any infected, deep, or large foot ulcer, especially chronic wounds or those overlying bony prominences, according to the Clinical Infectious Diseases 7

Off-Loading Requirements

  • The preferred treatment for neuropathic plantar ulcers is a non-removable knee-high off-loading device, as recommended by the Diabetes/Metabolism Research and Reviews 2

Wound Staging After Eschar Removal

  • Wounds covered by eschar are classified as "unstageable" because the extent of tissue damage is obscured, according to the Praxis Medical Insights 8
  • Once eschar is removed, use a sterile, blunt metal probe to determine actual depth, as recommended by the Praxis Medical Insights 8

Critical Pitfalls to Avoid

  • Premature removal of stable, dry eschar, especially on the heel, can lead to unnecessary tissue damage, as stated by the Praxis Medical Insights 1
  • Failure to recognize underlying infection requiring urgent intervention, according to the Praxis Medical Insights 1

When to Reassess or Escalate Care

  • If the wound shows no signs of healing within 6 weeks despite optimal management, consider revascularization regardless of initial vascular test results, as recommended by the Diabetes/Metabolism Research and Reviews 2
  • Re-evaluate patients at least daily if hospitalized, or in 3-5 days (or sooner if worsening) for outpatients, according to the Clinical Infectious Diseases 4

Vascular Assessment and Systemic Management of Diabetic Heel Eschar

Vascular Assessment

  • Ankle pressure and ankle‑brachial index (ABI) should be measured to confirm adequate arterial perfusion in patients with diabetic heel eschar. 9, 10, 11
  • Critical perfusion thresholds that mandate urgent vascular intervention are: ankle pressure < 50 mmHg, ABI < 0.5, toe pressure < 30 mmHg, or transcutaneous oxygen pressure (TcPO₂) < 25 mmHg. 9, 10, 11
  • When arterial perfusion is found to be inadequate, revascularization should be prioritized over local wound care. 9, 12

Revascularization and Escalation

  • If no wound improvement is observed after 6 weeks of optimal off‑loading and local care, clinicians should consider revascularization regardless of earlier vascular test results. 9, 10, 11

Systemic Risk‑Factor Management

  • Aggressive glycemic control is recommended for patients with diabetic foot wounds to promote healing. 9, 13
  • Comprehensive cardiovascular risk management—including statin therapy and antiplatelet agents—is advised for this population. 9
  • Smoking cessation support should be provided as part of standard care for diabetic foot ulcer patients. 9, 13

Multidisciplinary Care

  • Management of diabetic heel eschar should involve a multidisciplinary team (e.g., wound specialists, vascular surgeons, endocrinologists, and rehabilitation professionals) to address the complex needs of patients with pressure‑related ulcers and limited mobility. 13, 14

REFERENCES

1

Management of Large Stable Eschar on the Leg [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Management of Deep Tissue Injury (DTI) Without Eschar [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

Wound Staging After Eschar Removal [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025